HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: CJN.02190606v1 1/5/1108    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pei, Y. Search for Related Content PubMed PubMed Citation Articles by Pei, Y.

Diagnostic Approach in Autosomal Dominant Polycystic Kidney Disease

Divisions of Nephrology and Genomic Medicine Department of Medicine, University Health Network and University of Toronto, Toronto, Ontario, Canada

Address correspondence to: Dr. York Pei, 8N838, 585 University Avenue, University Health Network, Toronto, Ontario, Canada M5G2N2. Phone: 416-340-4257; Fax: 416-340-4999; E-mail: york.pei{at}uhn.on.ca

Autosomal dominant polycystic kidney disease (ADPKD) is the most common Mendelian disorder of the kidney and affects all racial groups worldwide. It is characterized by focal development of renal and extrarenal cysts in an age-dependent manner. Typically, only a few renal cysts are detected in most affected individuals before 30 yr of age. However, by the fifth decade of life, hundreds to thousands of renal cysts will be found in the majority of patients. ADPKD is genetically heterogeneous. Mutations of two genes, PKD1 and PKD2, account for approximately 85 and 15% of cases, respectively. Although the clinical manifestations of these two genotypes overlap completely, patients with PKD1 have much more severe renal disease compared with those with PKD2, as evidenced by their ESRD occurring approximately 15 yr earlier. Renal ultrasonography commonly is used for the assessment of ADPKD, and age-dependent ultrasound diagnostic criteria with high sensitivity and specificity have been established for individuals who are born with 50% risk for PKD1. Although these diagnostic criteria are used widely for genetic counseling and for the evaluation of at-risk individuals as living-related kidney donors to their affected relatives, their application to individuals who are at risk for PKD2 or have undefined genotype needs to be refined further. Molecular genetic testing is available for ADPKD and may be useful for evaluation of at-risk individuals with equivocal imaging results, younger at-risk individuals as a living-related kidney donor, and individuals with atypical or de novo renal cystic disease.

This article has been cited by other articles:

				E. Mezza, L. Biancone, F. Tattoli, M. Messina, L. Rizzo, E. Tola, and G. P. Segoloni 'Bench' MRI before transplant on harvested kidneys: a possible tool for diagnosis of acute pyelonephritis Nephrol. Dial. Transplant., November 11, 2008; (2008) gfn618v1. [Abstract] [Full Text] [PDF]

				I. Wu and C. R. Parikh Screening for Kidney Diseases: Older Measures versus Novel Biomarkers Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1895 - 1901. [Abstract] [Full Text] [PDF]

				X. Zhao, A. D. Paterson, A. Zahirieh, N. He, K. Wang, and Y. Pei Molecular Diagnostics in Autosomal Dominant Polycystic Kidney Disease: Utility and Limitations Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 146 - 152. [Abstract] [Full Text] [PDF]